Skip to main
ABCL
ABCL logo

AbCellera Biologics (ABCL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy AbCellera Biologics (ABCL) Stock

About AbCellera Biologics (ABCL)

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headq...read more
Market cap$955.15M
Today's volume7.1M
Revenue (TTM)$23.12M
Avg. daily volume4.61M
EBITDA (TTM)-$225.69M
Open$3
Price / earnings ratio-5.64x
Today's range$2.98 - $3.23
Debt / equity6.63x
52 week range$1.89 - $3.68
5 year debt / equity4.48x
Beta (LTM)1.29x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio10.15x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

AbCellera Biologics Stock Rating

What analysts recommend for ABCL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for ABCL stock is $955.16M

The current P/E ratio for ABCL stock is -5.64

The 52-week high for ABCL stock is $3.68. The current ABCL stock price $undefined is 100.00% below its 52-week high

The 52-week low for ABCL stock is $1.89. The current ABCL stock price $undefined has increased 100.00% from its 52-week low

No, the ABCL stock does not pay dividends to its shareholders

The target price for ABCL stock is $21.20 based on the average of what a group of analyst think ABCL stock could be worth at a future date. This is not a prediction by Public.com

How to buy ABCL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ABCL stock

    Navigate to the Explore page. Then, type ABCL into the search bar. When you see ABCL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ABCL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

AbCellera Biologics Stock Earnings

The value each ABCL share was expected to gain vs. the value that each ABCL share actually gained.

AbCellera Biologics (ABCL) reported Q1 2025 earnings per share (EPS) of -$0.15, missing estimates of -$0.14 by 7.14%. In the same quarter last year, AbCellera Biologics's earnings per share (EPS) was -$0.14. AbCellera Biologics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.

Buy AbCellera Biologics (ABCL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.